InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 0
Alias Born 08/27/2014

Re: BostonTrader post# 161699

Wednesday, 11/21/2018 7:50:56 AM

Wednesday, November 21, 2018 7:50:56 AM

Post# of 425931
BT...it’s the blame game as usual. Same whiners forget how JT and staff have steered this company thru the years eventually leading a landmark win against the omnipotent FDA. Sales have tripled in two years against a generic company with a small patient population. Just because things didn’t go the way some planned for their long awaited fortunes doesn’t mean things won’t work out for us. Bummed that we have to wait longer for catalysts such as exponential script counts and earnings, or possible buyout...but I have faith in JT’s direction and strategy. Execution is key...so far so good. If we all truly measured Amarin’s success by how many lives are saved or improved instead of pps performance we might be rewarded by a power much greater than our own.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News